# Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients

> **NCT01386554** · PHASE4 · COMPLETED · sponsor: **Mallinckrodt** · enrollment: 60 (actual)

## Conditions studied

- Proteinuria
- Idiopathic Membranous Nephropathy

## Interventions

- **DRUG:** Repository Corticotropin Injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01386554
- **Lead sponsor:** Mallinckrodt
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-08
- **Primary completion:** 2016-11-21
- **Final completion:** 2017-05-05
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01386554

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01386554, "Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01386554. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*